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INTRODUCTION 
  Acute pancreatitis is an acute inflammatory process involving 
pancreas and peri-pancreatic tissue, with a range of severity as well as 
various local and systemic complications. It is a common disorder causing a 
substantial burden on the healthcare system. The process involved in acute 
pancreatitis is complex in which pancreatic damage is caused by pancreatic 
enzyme activation, which results in an acute inflammatory response. 
  Usually, the clinical course of acute pancreatitis is mild and it 
resolves without any sequelae and carries the essentially minimal risk of 
mortality. But severe disease associated with Multi-Organ Dysfunction 
Syndrome (MODS) is present in 10-20% of patients. In this subset of 
patients, mortality rate reaches upto 30%.However,theindividual patient 
response to pancreatic injury is highly variable and unpredictable. Clinical 
biomarkers play a vital role in early patient triage, management and in 
predicting the development of life-threatening complications.  
   Patient with severe disease benefit from early detection of 
organ failure, antibiotic administration, and treatment for the etiological 
factors.                     
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The patient outcome can be increased by early detection ofthe severity 
of disease and triaging  patients correctly towards intensive care units based 
on severity. 
 Gallstones and alcoholism are associated with 80% of cases of acute 
pancreatitis. Individual association of alcohol and gallstones varies 
geographically. In a population where alcohol consumption is common, the 
incidence of alcohol-induced pancreatitis is substantially high. Trauma and 
drugs also cause acute pancreatitis. 
 Severe acute pancreatitis is defined by revised Atlanta classification 
of 2012 by the presence of organ failure that persists more than 48 hours. 
Organ failure is determined by assessing Cardiovascular, Respiratory and 
Renal systems. 
 Different scoring systems are being used to predict the severity of 
pancreatitis which includes APACHE II score, with 14 criteria and the 
RANSON’S score with 11 criteria. MOSS score with 12 criteria and BISAP 
score with 5 criteria are the newer scoring system. Balthazar described CT 
severity index which was modified into MCTSI (Modified CT Severity 
Index)  by Silverman et al in 2004. CTSI is calculated using CT scan 
features of acute pancreatitis and pancreatic necrosis. 
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   BISAP score is a 5 point bedside score. It is inexpensive to perform 
and easy to obtain. BISAP uses 5 points: Blood Urea Nitrogen (BUN) > 
25mg/dl, impaired mental status evidenced by disorientation or disturbance 
in mental status, the presence of SIRS, age >  60 years and Pleural Effusion. 
BISAP score has been shown to be accurate in predicting the severity of 
acute pancreatitis in the western population. 
The aim of this study is to apply BISAP score to a semi-urban 
population in Coimbatore and assess the accuracy of BISAP and MCTSI in 
the prediction of severity, pancreatic necrosis, and mortality in acute 
pancreatitis. If proved to be significant, we could avoid performing CT scan 
in patients with mild acute pancreatitis, which will drastically reduce the 
cost of treatment. 
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AIM AND OBJECTIVE 
     To compare BISAP (Blood Urea Nitrogen >25mg/dl, Impaired 
Mental Status, Systemic Inflammatory Response Syndrome, Age >60 and 
Pleural Effusion) score with modified computed tomography severity 
index(MCTSI) in predicting: 
a) Severity 
b) Pancreatic Necrosis 
c) Mortality in patients with Acute Pancreatitis. 
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REVIEW OF LITERATURE 
HISTORY OF PANCREATITIS 
Pancreas originated from a Greek word which means “all flesh”. In 
TALMUD written between 200BC and 200AD, thepancreas was referred to 
as the finger of  liver1. When William Harvey described circulation in 
Middle Ages, the pancreas was considered only as a pad to protect major 
vessels. It was Dr.Nicholas Tulp who first published a clear description of 
acute pancreatitis. In 1652 Dr.Reginald Filtz was the first to classify acute 
pancreatitis. He classified pancreatitis into hemorrhagic, suppurative and 
gangrenous forms. Pancreatic autodigestion as the pathophysiology behind 
acute pancreatitis was first postulated by Chiari. In 1896. Lord Moynihan 
quoted acute pancreatitis as1: 
  “ The most terrible of all calamities related with the abdominal 
viscera. The suddenness of its onset, the illimitable agony which 
accompanies it and the mortality  attendant upon  it, all renders it the most 
formidable of catastrophies.”  
It is believed that Alexander the Great (323 BC) died out of  Acute 
Pancreatitis. 
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ANATOMY OF PANCREAS 
The pancreas is a retroperitoneal organ. It is divided into head, neck, 
body, and tail. Head constitute 30% of the gland by mass. Body and tail 
constitute rest 30%. Head occupies the space within the ‘C’ loop of 
duodenum2. The position of head corresponds to the body of second lumbar 
vertebrae. Behind the neck of pancreas lies aorta and superior mesenteric 
vessels. Superior mesenteric vein joins the splenic vein to form portal vein 
behind the neck of the pancreas. Tip of pancreatic tail reaches upto hilum of 
spleen.3 
 
Figure 1. The five parts of the pancreas. The division between body and tail is 
arbitrary 
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  The weight of pancreas is 80 grams. 90% of its mass is 
composed of exocrine acinar cells. Main pancreatic duct branches into 
interlobular, intralobular ducts, ductules and acni. The lining of pancreatic 
duct is by columnar epithelium. In ductules it becomes cuboidal. 4Clusters of 
endocrine cells called Islets of Langerhans1 are distributed throughout the 
pancreas. B cells producing insulin constitute 75% of islet cells. A cells 
producing glucagon contribute 20% of islet cells. Rest is formed by D cells 
which produce somatostatin. Pancreatic portal system is formed by 
capillaries that drain islet cells to portal vein.5 
 
 
Figure 2.  A:Pancreatic acini and islet cells B: Four progressive stages in the 
organization of islands. 
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Figure 3. Relations of pancreas A: Anterior relation B: Posterior relation 
 
PANCREATIC EMBRYOGENESIS 
From the dorsal side of the duodenum, closed pancreatic duct arises 
by 26 days of gestation. Ventral bud arises from the base of hepatic 
diverticulum by day 32. The 2 buds come in contact by 37 days of gestation 
and its fusion occurs by the end of 6th week.6 Head and uncinate process are 
formed from the ventral bud. The main pancreatic duct of Wirsung is formed 
from the ventral duct and distal portion of dorsal duct.4 Proximal dorsal duct 
forms the duct of Santorini. All these processes of duct fusion occur by 
the6th week. Pancreatic acini and islets begin to appear by the3rd month. 
Annular pancreas is formed due to malrotation of ventral bud. 
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Figure 4. Blood supply of pancreas 
 
PHYSIOLOGY 
After meals, pancreas secretes digestive enzyme in an alkaline 
bicarbonate rich fluid of pH 8.4. Secretin is produced from duodenal 
mucosa.7                                        
  It produces bicarbonate rich fluid in response to food. Duodenal 
mucosa produces cholecystokinin.CCK is responsible for enzyme release.. 
Volume of secretion is increased by vagal stimulation.2 
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DEFINITION 
 Pancreatitis is defined as inflammation of parenchyma of the 
pancreas. It is divided into acute and chronic pancreatitis based on disease 
process and clinical presentation.8Acute Pancreatitis presents as an acute 
abdomen with abdominal pain and is usually associated with a raised 
pancreatic enzyme in blood or urine.9 It is due to the prematureactivation of 
enzymes within the pancreas, leading to autodigestion of  pancreas.10 
ETIOLOGY 
Many factors have been identified to cause acute pancreatitis. But the 
exact mechanism in all cases is poorly understood.Gallstones and alcohol 
cause 80% of acute pancreatitis.3 In some cases no specific etiological 
agents are identified. In order to identify uncommon and modifiable risk 
factors, a systemic approach to acute pancreatitis is important.11Etiology 
plays an important role in determining the median age of presentation of 
aute pancreatitis. For example, the median age of presentation of alcohol 
induced pancreatitis is in the 3rd and 4th decade and gallstone and trauma 
induced pancreatitis present is in the sixth decade. Etiology also influences 
the gender difference in presentation. In males alcohol more often causes 
pancreatitis but in female gall stones12.Etiological factors of Acute 
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Pancreatitis are classified into metabolic factors, mechanical factors, 
vascular factors and infection.13 
METABOLIC FACTOR 
 Alcohol 
 Hyperlipoproteinemia11 
 Hypercalcemia 
 Hyperparathyroidism10 
 Drugs like 5-Aminosalicylates11, 6 mercaptopurine, 
azathioprine, tetracyclinesvalproic acid, L-asparginase and 
diuretics like frusemide and thiazides.3 
 Scorpion venom 
MECHANICAL FACTOR 
 Cholelithiasis14 
 Postoperative patients 
 Congenital anomalies like Pancreatic Divisum4 
 Post abdominal trauma 
 Post ERCP15 
 Pancreatic duct obstruction by tumor, ascaris. 
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VASCULAR FACTOR 
 Postoperative (cardiopulmonary bypass) 
 PAN(Poly Arteritis Nodosa) 
 Thromboembolism 
INFECTION 
 Coxsackie B virus 
 Cytomegalovirus 
 Mumps & Cryptococcus 
Surgeries causing pancreatitis include8: 
a. Surgeries in and near pancreas  
 1.Pancreatic Biopsy 
 2. Distal Gastrectomy  
 3.Splenectomy  
 4.CBD exploration 
b. Surgeries using low systemic perfusion like 
 Cardiac bypass(cardiopulmonary bypass) 
 Cardiac transplantation 
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GALLSTONES 
Gall stone is an important etiology for the development of acute 
pancreatitis. In patients with acute pancreatitis, the liver function test is 
usually deranged. Also gall stones are retrieved from the faeces of patients 
with acute pancreatitis within 10 days of an attack of AP. These factors 
provides evidence to support that passage of gallstones may be the factor 
behind the development of Acute Pancreatitis14.  
 
Figure 5. Gallstone causing pancreatitis 
 
The mechanism by which gallstone causes acute pancreatitis is 
explained by “common channel” hypothesis. It is proposed that reflux of bile 
into pancreatic duct occurs when gall stones lodge in distal part of common 
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bile duct near Ampulla of Vater. Another study suggests that transient 
incompetence to the sphincter is caused by the passage of stone through the 
sphincter. This incompetence will lead to reflux of bile and duodenal fluid to 
pancreatic duct16. A third study propose that gallstone may obstruct 
pancreatitis duct directly leading to ductal hypertension which leads to back 
pressure and ductal  disruption and extravasation  of pancreatic juices.17 
ALCOHOL 
Alcohol consumption is related with acute pancreatitis, recurrent 
pancreatitis, and chronic pancreatitis. Amount of alcohol consumed is more 
important than the type of alcohol consumed. The pattern of drinking is also 
important. There is always a history of excess alcohol consumption prior to 
the first attack. Ethanol damages acinar cells and disturbs its metabolic 
activity. Acute pancreatitis is triggered by secretory burst following alcohol 
intake coupled with ethanol induced spasm of the sphincter of Oddi.10 
Ethanol increases the ductal permeability which leads to leakage of 
pancreatic enzymes causing damage to pancreatic parenchyma. Protein 
content of  pancreatic juice is increased by alcohol thereby forming protein 
plug and cause obstruction to pancreatic outflow.10 
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IATROGENIC 
Procedures like biopsy of pancreas, distal gastrectomy, exploration of 
common bile duct, repair of aortic aneurysm and retroperitoneal lymph node 
excision are some iatrogenic causes of acute pancreatitis. Splanchnic 
hypoperfusion with cardiopulmonary bypass and cardiac transplant can lead 
to pancreatitis as pancreas is highly susceptible to ischemia18. Worldwide 
post ERCP accounts for 3rd most common identified etiological factor for 
AP. If contrast is used repeatedly in ERCP, the chance of developing AP is 
much higher. 
TECHNIQUES TO REDUCE ERCP- INDUCED PANCREATITIS 
Avoid solely diagnostic ERCPs to the maximum. It should be 
replaced by low risk tests such as MRCP. Perform ERCP as a therapeutic 
procedure whenever possible. Limiting the number of attempts of pancreatic 
duct cannulation and limiting the number of contrast injection into 
pancreatic duct and slow injection of contrast are other methods to reduce 
ERCP induced pancreatitis. A transpapillary pancreatic duct stent must be 
placed in high risk patients.  
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HEREDITARY PANCREATITIS19 
It is an autosomal dominant disorder due to mutation of cationic 
trypsinogen gene (PDSS-1). Mutation in this gene causes premature 
activation of trypsinogen to trypsin and promote acute pancreatitis. Mutation 
in SPINK -1 protein gene will also lead to acute pancreatitis. 
PANCREATIC DIVISUM 
Pancreatic divisum is a common congenital disorder seen in 7% of 
population.The absence of fusion of dorsal and ventral bud leads to this 
anomaly. Pancreatic divisum may result in a stenosed or inadequately patent 
minor duct papilla which prevents normal drainage of pancreatic secretion. 
This may result in increased intraductal pressure. The relation between 
pancreatic divisum and pancreatitis is highly controversial. Another 
controversial issue is the relation between Sphincter of Oddi Dysfunction 
and acute pancreatitis. This also results in increased intraductal pressure. 
Biliary sludge is a viscous suspension of bile and it consists of cholesterol 
crystals and calcium bilirubinate granules which are embedded in strands of 
gallbladder mucus. Sludge is associated with bile stasis and biliary duct 
obstruction. In patients with recurrent acute pancreatitis, biliary sludge is 
commonly seen. Such patients are benefited by cholecystectomy.  
17 
 
PATHOPHYSIOLOGY OF ACUTE PANCREATITIS 
   Acute pancreatitis is the end result of abnormal enzyme activation 
within the pancreatic acinar cells.20 The earliest step is co-localization of 
zymogen granules and lysosomes inside the acinar cells. This step occurs 
well before the elevation of serum amylase and onset of pancreatic 
edema.21Once cathespin-B in lysosomes and trypsinogen in zymogen 
granules are brought in contact by co–localization induced by 
pancreatitis,trypsinogen gets activated to trypsin22. This trypsin induces leak 
of colocalized organelles,releasing more cathespin-B into cytoplasm leading 
to apoptosis and necrosis of acinar cells. 
          Intra acinar enzyme activation induces autodigestion of normal 
pancreatic parenchyma, leading to the release of proinflammatory cytokines 
such as tumor necrosis factor –alpha (TNF –α) and interleukins IL-1,IL-2 & 
IL-6.20These inflammatory cytokines recruit neutrophils and macrophages 
into the pancreatic parenchyma and cause release of more TNF-α, IL-1 and 
IL-6,reactive oxygen species,prostaglandins, platelet activating factors and 
leukotrienes.4 These inflammatory mediators increase the permeability and 
damages the microcirculation and further aggravates pancreatitis. In severe 
cases, local hemorrhage and pancreatic necrosis occurs.23 
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                 In 80-90%of cases, this inflammatory cascade is self-limiting. In 
rest of patients,a vicious cycle of pancreatic injury ,local and systemic 
inflammatory reaction occurs. This leads to them assive release of 
inflammatory mediators into systemic circulation causing Multi Organ 
Dysfunction .16 Active neutrophils causes acute lung injury and induce Adult 
Respiratory Distress Syndrome. Most common cause of death in Acute 
Pancreatitis is Multi Organ Dysfunction Syndrome (MODS).24The first sign 
of  MODS in Acute Pancreatitis is impaired lung function due to ARDS. 
Mortality in first two weeks is due to multi-organ dysfunction. Death in late 
phase is due to sepsis related complications. 
 To summarize, cathepsin B mediated intra acinar cell activation of 
digestive enzymes leads to acinar cell injury which triggersinflammatory 
response. The released  proinflammatory cytokines propagate response 
locally and systemically.24 
19 
 
 
Figure 6. Stimulation of acinar cells leads to colocatisation of lysosomes and 
zymogen.Intracytosolic calcium is needed for colocalisation.Cathepsin B activates 
trypsingen to trypsin. Trypsin results in apoptosis.Mitochondria releases 
cytochrome c. Released cytokine attracts inflammatory response cells, finally 
leading to systemic and local inflammatory response. 
CLINICAL PRESENTATION OF ACUTE PANCREATITIS 
Most common symptom of pancreatitis is pain. Maximum intensity is 
reached within minutes and pain persists for hours. Pain is constant and 
refractory to the usual dose of analgesics10. Pain is first experienced in 
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epigastrium and it may gradually localize to either upper quadrant or 
diffusely over entire abdomen. 
Radiation of pain to back is present in 50%of cases. Patient  
experience mild relief of pain on stooping forward. Acute pancreatitis 
mimics most of the acute abdominal conditions. Nausea, vomiting ,retching 
may be associated  with pain.25 
On examination, the general appearance can vary from normal to 
severely ill depending on the severity of the disease. In patients with severe 
acute pancreatitis tachypnea, tachycardia and hypovolemia may be 
present9. Due to the presence of inflammation, the patient may have elevated 
body temperature. Acute swinging pyrexia suggest cholangitis.26 
Bleeding into the fascial planes can produce discoloration of 
abdominal wall. Bluish discoloration of flanks is known as Grey Turner sign 
and that of umbilicus is known as Cullen's sign. Subcutaneous fat necrosis 
leads to small red tender nodules on the skin of legs.27 
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Figure 7. Grey Turner sign 
On abdominal examination, distension may be present if there is ileus. 
Ascites may be present presenting as shifting dullness. Guarding in the 
upper abdomen is commonly seen but rigidity is rarely seen.3 Pleural 
effusion present in 10-20% patients signs of metabolic derangement and 
hypoxemia may be seen in severe cases. 
INVESTIGATIONS 
Serum amylase level usually increases to 3-4 fold level. It is one of 
the diagnostic criteria of acute pancreatitis. 28A normal serum amylase level 
does not exclude acute pancreatitis. If the patient presents late, amylase 
value may be high. Serum lipase level is more sensitive and specific than 
serum amylase. The single best investigation for acute pancreatitis is 
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contrast enhanced CT29. Sentinel loop sign, colon cut-offsign and renal halo 
sign are seen in plain X-ray abdomen in acute pancreatitis. Because of spasm 
of distal bowel overlying inflamed pancreas, the bowel is focally dilated 
proximally and is called sentinel loop sign. Colon cut off sign is the focal 
dilation of mid transverse colon. It is due to the extension of peripancreatic 
inflammation and bowel spasm at splenic flexure. Widening of C- loop of 
duodenum occurs due to edema and inflammation of pancreatic head. 
Calcification may be present in X-ray. Chest X-ray may show pleural 
effusion or findings of ARDS. 
 
Figure 8. Colon cut off sign shown by arrow 
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In ultrasonography, swollen and edematous pancreas may be visualized. 
Gallstones can also be demonstrated in USG. 
Indications of contrast enhanced CT in Acute  Pancreatitis are29: 
 When there is diagnostic uncertainty. 
 In patient with severe acute pancreatitis. 
 In the presence of organ failure and signs of sepsis. 
 In the presence of localized complications such as fluid 
collection, pseudocyst, and pseudoaneursym. 
DIAGNOSIS 
The diagnosis of Acute  Pancreatitis  requires two of the  following 
three features:30 
1.Abdominal pain consistent with acute pancreatitis (onset of an 
acute, severe, persistent, epigastric pain which often radiates to 
the back) 
2. Serum amylase or lipase level at least three times higher than 
the upper limit of normal range. 
3.Characteristic sign of Acute Pancreatitis on contrast enhanced 
computed tomography (CECT), magnetic resonance imaging 
(MRI) or transabdominal  ultrasonography. 
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CLASSIFICATION  OF ACUTE PANCREATITIS 
Acute pancreatitis is classified into 2 types:31 
1.Acute interstitial oedematous pancreatitis 
2.Acute necrotizing pancreatitis 
ACUTE INTERSTITIAL OEDEMATOUS PANCREATITIS 
   It accounts for around 80-90% of cases. it is a milder form of Acute 
Pancreatitis and usually, resolves in one week. The pancreas is diffusely 
enlarged(occasionally localized)due to inflammation23. In contrast CT there 
is homogenous enhancement of contrast in pancreas with no evidence of 
necrosis in pancreatic parenchyma and peripancreatic tissue. The 
peripancreatic fat shows haziness or mild stranding due to inflammation 
,minimal peripancreatic fluid may also be present. 
ACUTE NECROTIZING PANCREATITIS 
It is characterized by the presence of tissue necrosis in pancreatic 
parenchyma, peripancreatic tissue or both. It is a more aggressive form of 
acute pancreatitis and most commonly manifests as necrosis of both 
pancreatic & peripancreatic tissue, less commonly as necrosis of 
peripancreatic tissue alone and rarely as pancreatic necrosis alone.32 The 
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extent of necrosis is underestimated by early CECT as compromise of 
pancreatic perfusion and features of peripancreatic necrosis evolve over 
several days. Necrotising pancreatitis has a variable course as the necrotic 
tissue may remain sterile or get infected, may remain solid or liquefy, may 
persist or disappear over time9. 
COMPLICATION OF ACUTE PANCREATITIS 
LOCAL  COMPLICATIONS 
When there is persistent abdominal pain, secondary elevation in 
pancreatic enzyme level, progressive organ dysfunction or signs of sepsis, 
local complications of Acute Pancreatitis are suspected. Local complications 
are acute peripancreatic fluid collection, pancreatic pseudocyst, acute 
necrotic collection, walled off necrosis, gastric outlet obstruction, colonic 
necrosis, splenic or portal vein thrombosis.2 
1.ACUTE PERI - PANCREATIC FLUID COLLECTION 
The peripancreatic fluid collection is associated with interstitial 
edematous pancreatitis with no necrosis within first four weeks after onset of 
disease. Imaging shows a homogenous collection of fluid adjacent to 
pancreas without a well defined wall encapsulation. 
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2.PANCREATIC PSEUDOCYST 
A pseudocyst is a collection of pancreatic juices that arise as a 
consequence of acute pancreatitis, pancreatic trauma or chronic pancreatitis 
and is enclosed by a nonepithelialized wall (Atlanta International 
Symposium 1992).Imaging shows well circumscribed homogenous fluid 
collection with well defined wall33.Pseudocyst occurs in 5-15% of patient 
who has APFC. The wall is made of collagen or granular tissue and fluid is 
rich in amylase. 
 
Figure 9. Pancreatic Pseudocyst 
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3.ACUTE NECROTIC COLLECTION 
It is a collection of solid and liquid components without a well defined 
wall involving pancreatic extra pancreatic tissue or both in the setting of 
necrotizing pancreatitis. Imaging studies shown an encapsulated 
heterogenous collection of varying density. 
 
Figure 10. Pancreatic Necrosis 
 
4.WALLED OFF NECROSIS 
It is an encapsulated collection in the setting of necrotizing 
pancreatitis, four weeks after onset of disease. Imaging shows heterogeneous 
collection with varying degree of  localization with well defined wall.10 
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5.INFECTED PANCREATIC NECROSIS 
The necrotic tissue rarely gets infected. Infection can be suspected 
when there are signs of ongoing sepsis and confirmed by image guided fine 
needle aspiration, which may show frank pus or presence of bacteria and 
fungi on microscopic examination. Infected pancreatic necrosis requires 
antibiotic and the infected material needs to be drained. 
Pancreatic ascites, pancreatopleuralfistula,pancreatocutaneous fistula and 
vascular complications are other local complications of acute pancreatitis 
 
 
Figure 11.Infected Pancreatic Necrosis. The air bubble in necrotic debris indicates 
infected necrosis 
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SYSTEMIC COMPLICATIONS 
Worsening of pre-existing comorbidities such as coronary artery 
disease, obstructive pulmonary disease in the setting of acute pancreatitis is 
considered under systemic complications. 
ACUTE PANCREATITIS IN PREGNANCY 
 The incidence of acute pancreatitis in pregnancy is 0.1%. Gestational 
sex hormones like estrogen have cholestatic effect and therefore gallstones 
are the most common cause of acute pancreatitis in pregnancy. As in other 
cases of acute pancreatitis, the presentation is with typical epigastric pain 
which radiates to back. As serum lipase levels are unaffected by pregnancy, 
it is of high diagnostic significance in pregnancy. In a normal pregnancy, 
there is mild elevation in serum amylase levels. Cholelithiasis and bile duct 
dilation are preferably detected by abdominal ultrasonography. CT is 
avoided in pregnancy. Due to the presence of overlying gravid uterus and 
bowel gas, the pancreas is usually poorly visualized in pregnancy. The 
course of acute pancreatitis is usually mild during pregnancy and respond 
well to medical therapy. For symptomatic choledocholithiasis during 
pregnancy, an endoscopic sphincterotomy is a safe option.  
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SEVERITY OF ACUTE PANCREATITIS 
The revised Atlanta classification of acute pancreatitis (2012) is an 
international multidisciplinary classification of Acute Pancreatitis severity. It 
is an update of 1991 Atlanta classification of acute pancreatitis. It classifies 
acute pancreatitis into Mild, Moderate and Severe acute pancreatitis.9 
In mild pancreatitis32 there is no organ failure. Moderate acute 
pancreatitis is defined by transient organ failure less than 48 hrs.  Severe 
acute pancreatitis is defined by persistent organ failure that persists longer 
than 48 Hrs. 
Organ failure is defined by : 
 Shock – Systolic Blood Pressure of<90 mmHg 
 Pulmonary Insufficiency –Pao2 <60 mm Hg at room air or need 
for mechanical ventilation 
 Renal Failure – Serum creatinine level>2 mg/dl after 
rehydration or hemodialysis 
 Gastrointestinal Bleeding>500ml/24 hrs 
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Figure 12. Histology of acute pancreatitis showing hemorrhageand inflammatory 
cells. 
 
ASSESSMENT OF SEVERITY OF ACUTE PANCREATITIS 
There are different scoring systems that are designed to evaluate the 
severity of Acute Pancreatitis.  
RANSONS SCORE34 
The earliest scoring system is Ransons (1979). It predicts the severity 
of disease on the basis of 11 parameters obtained at the time of admission & 
48 hours later35. The advantage of this scoring system is that it does not 
predict the severity of the disease at the time of admission because six 
parameters are assessed only after 48 hours of admission. 
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RANSONS SCORE FOR NON GALLSTONE PANCREATITIS 
At Presentation 
 Age > 55 years 
 Blood glucose level > 200 mg/ dl 
 Lactate dehydrogenase level > 350 IU/L 
 Aspartate amino transferase > 250 IU/L 
After 48 hours of admission 
 Hematocrit decrease > 10 % 
 Serum Calcium level < 8 mg /dL 
 Base deficit > 4 mEq/L 
 Blood urea nitrogen level increase > 5mg/dL 
 Fluid requirement > 6 litres 
 PaO2 < 60 mm Hg 
In the case of Gallstone pancreatitis, cut off values for some 
parameters changes. Age more than 70 years, Blood glucose level more than 
220mg/dl, WBC more than 18,000 cells/mm3 and LDH more than 400 
IU/liter are taken at admission. In the after 48 hours calculation, base deficit 
more than 5mEq/L, blood urea nitrogen level increase more than 2mg/dl and 
fluid requirement more than 4 litres are taken into consideration. 
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APACHE II 
Acute physiology and chronic health evaluation(APACHE II)score 
also addresses the severity of acute pancreatitis. It is based on the patient's 
age ,previous health status, and 12 routine physiologic measurements. An 
APACHE II score of 8 or more defines severe pancreatitis. The advantage of 
APACHE II scoring system is that it can be used on admission and repeated 
at any time. The disadvantage is that it is complex and not specific for acute 
pancreatitis36 
Variables that determine  APACHE II score are :31 
 Rectal Temperature   
 Mean Arterial Blood Pressure 
 Heart Rate 
 Respiratory Rate 
 Oxygenation ( PaO2) 
 Arterial pH and Bicarbonate level 
 Serum Sodium, Potassium and Creatinine 
 Hematocrit and White Blood Cell count 
 Glasgow Coma Scale 
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CT SEVERITY INDEX (CTSI)29 
Balthazar and his associates established the CT severity index using 
imaging characteristics. This index correlates CT finding with the patient's 
outcome. 
Following are the parameters considered in CTSI for acute 
pancreatitis: 
PANCREATIC INFLAMMATION       POINTS 
 Normal Pancreas       0 
 Enlargement of the Pancreas     1 
 Peripancreatic inflammation     2 
 Single acute peripancreatic fluid collection   3 
 Two or more peripancreatic fluid collection   4 
 
PANCREATIC NECROSIS 
 None         0 
 Less than 30 %       2 
 30% to 50%        4 
 More than 50%       6     
MAXIMUM POINTS                 10 POINTS  
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CT severity index is now rarely used in practice. It is replaced by 
Modified CT severity index in 2004.It accounted for all the potential 
limitations of CTSI. It simplified the evaluation of pancreatic parenchymal 
necrosis and peripancreatic inflammatory changes. It also considered 
extrapancreatic complications in the assessment scale. 
Parameters considered in the MCTSI are the following. 
PROGNOSTIC INDICATOR                                                  POINTS                                                              
PANCREATIC INFLAMMATION 
Normal Pancreas        Point  0 
Intrinsic pancreatic abnormality     Point  2 
Peripancreatic fluid collection      Point 4 
PANCREATIC NECROSIS   
Absent         Point 0 
< 30 percentage        Point 2 
≥ 30 percentage        Point 2 
EXTRA PANCREATIC COMPLICATIONS   Point 2 
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Extrapancreatic complications considered in the index are pleural 
effusion, ascitis, vascular complications, parenchymal complications and 
gastrointestinal tract involvement. 
 
BISAP SCORE 
Wu et al introduced BISAP score. It is simple 5 point bedside score 
and is easy to obtain and inexpensive. The BISAP score was originally 
retrospectively derived and validated based on a large population data 37. 
Parameters assessed in BISAP score are: 
 BUN   : Blood urea nitrogen  > 25 mg /dl 1 Point 
 Impaired Mental Status: GCS less than 15   1 Point 
 SIRS   :  Evidence of SIRS   1 Point 
 Age   : Age more than 60 years   1 point 
 Pleural effusion : Evidenced by imaging study  1 point  
 
 
PHASES OF ACUTE PANCREATITIS 
Acute pancreatitis is divided into early and late phases, in 
pathophysiological terms. 
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A.EARLY PHASE 
Early phase22 occurs in the 1st week after onset. In this phase disease 
manifest as a systemic inflammatory response. Hence, host response to 
cytokine cascade lead to systemic inflammatory response(SIRS)or 
compensatory anti-inflammatory syndrome(CARS)and may progress to 
organ failure which may be single or multiple (multi-organ failure).In this 
phase ,clinical severity and treatment are mainly determined on the basis of 
type and degree of this organ failure 
B. LATE PHASE 
Late phase generally starts in the2nd week and can last for weeks to 
months. Late phase occurs only in patients with moderately severe or severe 
pancreatitis. This phase is defined by persistent organ failure and by local 
complications  
MANAGEMENT OF ACUTE PANCREATITIS 
Management of acute pancreatitis involves accurate diagnosis, proper 
triaging of patients, high quality supportive care, monitoring for early 
detection and treatment of complications and prevention of relapse.16 
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TRIAGE  
All patients diagnosed to have acute pancreatitis should be 
hospitalized for supportive therapy and proper management. All cases of the 
first episode of pancreatitis must be admitted and evaluated to determine the 
specific cause. Patients with early signs of organ failure must be monitored 
in an intensive care unit. General supportive therapy to prevent 
complications, directed therapy for specific causes of pancreatitis and early 
recognition and treatment of complication are theprimary goal of therapy.  
MANAGEMENT OF: 
A.SYSTEMIC INFLAMMATORY RESPONSE SYNDROME PHASE 
Adequate fluid resuscitation and adequate pain relief are the most 
important considerations in this phase.31 Fluid should be given attaining a 
goal of 1mg/kg/hr urine output in this phase. In the initial 24 hours of severe 
acute pancreatitis close monitoring and intravenous fluid, supplementation 
are pivotal. Crystalloids are the ideal fluid of choice.25 
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B.COUNTERACTIVE ANTIINFLAMMATORY RESPONSE 
SYNDROME PHASE 
Infection of pancreatic necrosis and peripancreatic collections must be 
thought of, if the patient deteriorates even after initial resuscitation. Decision 
on intervention is made based on clinical status of the patient.2 
PREVENTION OF INFECTION 
Many prophylactic strategies are tried to prevent infection as the 
infection is associated with increased mortality in acute pancreatitis. Enteral 
bacteria is the usual culprit of infection. These bacteria cross the mucosal 
barrier in the first 24 hours of disease. Intravenous antibiotics, enteral 
nutrition, selective bowel decontamination and enteral probiotics are tried to 
reduce infection. 
    Recent studies show that early enteral nutrition reduces small bowel 
bacterial overgrowth and improve intestinal mucosal barrier functions. 
In patients with mild pancreatitis, oral feeding can be started after one 
day. In severe pancreatitis, enteral nutrition by nasojejunal feeding tube can 
be started by 3 days. 
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Recent studies disproved the beneficial effect of prophylactic systemic 
antibiotics in acute pancreatitis. Since gut is the source of bacteria 
responsible for the infectious complications,in acute pancreatitis,selective 
bowel decontamination with Norfloxacin ,Colistin and Amphotericin are 
under consideration9. 
INTERVENTIONS IN ACUTE PANCREATITIS 
In the first 2 weeks, i.e phase of systemic inflammatory response 
syndrome, there is no room for intervention for pancreatic necrosis38. Acute  
interventions are justified only in the presence of  : 
 abdominal compartment syndrome 
 bowel ischemia/ perforation 
 severe bleeding unresponsive to angiographic coiling 
Abdominal Compartment Syndrome is defined as intra abdominal pressure, 
more than 20 mm Hg with signs of new organ failure. 
In severe biliary pancreatitis and cholestasis ( Bilirubin 2.3mg/dl or 
dilated common bile duct) ERCP with endoscopic sphincterotomy reduces 
the risk of progression to complications.39 
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In the second counter anti inflammatory response syndrome 
phase(CARS),there is increased the risk of systemic infection or sepsis 
caused by secondary infection of pancreatic necrosis. The most accepted 
indication for intervention is documented on a suspected infection of 
pancreatic/ peripancreatic necrosis with signs of sepsis. The intervention can 
be done radiologically,endoscopically or surgically40. 
Choice and timing of intervention is determined by a multidisciplinary 
team. Based on the current literature postponding the intervention preferable 
until 4 weeks after onset of the disease is accepted as the strategy of choice. 
By this time the collection will be encapsulated and is referred as “walled off 
necrosis”. However, the length of interval is determined by the completeness 
of encapsulation  and clinical condition of the patient.41 
TYPES OF INTERVENTION FOR TREATING INFECTED 
NECROSIS 
A  .CATHETER  DRAINAGE 
It is the least invasive technique for treating infected necrosis. The 
drain is placed percutaneously through left retroperitoneum 
ortransabdominally. If patient fails to improve after adequate drainage, next 
step is performing necrosectomy.   Percutaneous drain can be used as a 
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roadmap for necrosectomy. This two step approach ,first drainage, and 
second drain guided minimally invasive necrosectomy is called the STEP 
UP APPROACH 
B . MINIMALLY INVASIVE NECROSECTOMY 
It is video-assisted retroperitoneal debridement (VARD) procedure. In 
this procedure, Zero degree laparoscope is introduced guided by the 
previously placed drain. All necrotic material in reach are removed under 
direct vision. After debridement two large bore drains are kept into the 
empty cavity and continuously lavaged with 0.9% normal saline is done for 
3 days 
C .ENDOSCOPIC TRANSLUMINAL NECROSECTOMY  
Endoscopic transluminal / transgastric necrosectomy is performed 
when VARD is not feasible. This procedure needs to be repeated multiple 
times to remove sufficient amount of necrotic material. 
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Figure 13.Video Assisted Retroperitoneal Debridement and Endoscopic 
Transluminal Necrosectomy 
 
D. OPEN NECROSECTOMY 
It is done in two ways. The first method includes laparotomy with 
placement of a retroperitoneal lavage system after complete necrosectomy 41. 
Drains placed in lesser sac are continuously lavaged with normal saline. In 
the second method, after removing all necrotic tissue and debris,the resulting 
cavity is packed with gauge stuffed pentrose drains. These gauze stuffed 
drains are removed one by one after one week. 
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Figure 14. Necrosis is often seen through the transverse mesocolon after opening the 
abdomen. 
 
Figure15. A. During open necrosectomy, a small window is made ingastrocolic 
omentum B. Necrosis accessed through lesser sac by extending the window 
 
45 
 
FUTURE DIRECT OF RESEARCH 
Till now the treatment of acute pancreatitis remains non specific and 
mainly supportive, focusing mostly on intensive care. Recent immune 
modulatory therapeutic attempts in experimental models is driven by the 
presence of inflammatory response syndrome during Acute Pancreatitis.20 It 
includes cytokines, chemokines, immune cells and other inflammatory 
mediator blockade. Recent studies in animal models showed that TNF 
antagonism by either TNF receptor blockade or anti-TNF antibodies 
protected them from local intra pancreatic damage, systemic complications, 
and overall mortality. Administration of Infliximab appears to decrease 
serum amylase levels in both edematous and necrotic pancreatitis in murine 
models17 
 Pro-inflammatory cytokines such as IL- 6 and IL- 1 are released in 
acute pancreatitis with their plasma concentration correlates with severity of 
the disease and occurrence of multi organ failure. But anti inflammatory 
mediators such as   IL-10 levels seems to be inversely proportional to the 
severity of pancreatitis 
 Blockade of  the IL-1 receptor by either targeted genetic disruption or 
pharmacological agents reduced the extent of intra-pancreatic damage and 
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systemic complications. IL-10 has been shown to have a protective effect in 
several models of acute pancreatitis. It significantly ameliorates organ 
specific damage in the pancreas and peripancreatic tissue including lungs 
and liver. 
 Studies showed that when PAF antagonists were applied 
therapeutically, local intra pancreatic damage and micro circulating 
derangements were significantly reduced. Most promising among them are 
Lexipafant. 
 Expression of adhesion molecules is central for the development of 
endothelial barrier dysfunction, transmigration of neutrophils and 
development of organ dysfunction. Treatment with antibodies against 
adhesion molecules like ICAM – 1 and platelet endothelial cell adhesion 
molecules – 1 has shown to be effective in experimental models42 
 In murine model, Hydrocortisone has reduced mortality and blood 
cytokine levels. Treatment of acute pancreatitis by immune modulation 
currently represents an attractive and highly promising concept.  
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MATERIALS AND METHOD 
The study was concluded in the Department of General Surgery, 
Coimbatore Medical College Hospital from July 2016 to June2017. This 
study was approved by the ethical committee of Coimbatore Medical 
College Hospital. Nature, methodology, and risks involved in the study were 
explained to the patient and informed consent was obtained. The information 
collected from the patients and their case records were kept confidential. All 
provisions of the Declaration of Helsinki were followed in this study. 
STUDY DESIGN 
   Diagnostic Test  Evaluation. 
STUDY POPULATION 
 100 patients who were admitted to general surgical ward and 
diagnosed to have Acute Pancreatitis during the study period from July 2016 
to June 2017 were included in the study. 
INCLUSION CRITERIA 
  All patients admitted with the diagnosis of Acute Pancreatitis based on 
the presence of at least two of the following three criteria: 
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1. Characteristic epigastric abdominal pain, with or without 
radiation to the back. 
2. Serum amylase or lipase levels elevated to at least three times 
the upper limit of normal. 
3. Characteristic finding of Acute Pancreatitis on abdominal CT 
scan. 
EXCLUSION CRITERIA 
    Patients with pre existing Chronic Kidney Disease (CKD) which may be 
associated with elevated Blood Urea Nitrogen values were excluded from 
the study as they may result in a high BISAP score. 
METHOD 
     All patients with Acute Pancreatitis presenting to the Department of 
General Surgery who fit the inclusion criteria were included in the study 
after obtaining informed consent. Extensive demographic, radiographic and 
laboratory data which includes complete haemogram, serum electrolytes, 
renal function test, liver function test, serum amylase, lipid profile, chest X-
ray, USG abdomen etc were collected. BISAP score was calculated using 
data from the first 24 hours from admission. A score of 1 is given for each 
criteria for a maximum score of 5. 
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CRITERIA  FOR BISAP SCORE: 
  BUN more than 25mg/dl 
 Abnormal mental status with GCS < 15 
 Evidence of SIRS 
 Age > 60 years 
 Presence of Pleural Effusion on X Rays 
One point is given for each score. 
SIRS is defined by the presence of >2 of the following criteria: 
 Pulse rate >  90/min 
 Respiratory rate  > 20/min or PaCO2 <  32mm Hg 
 Temperature  > 100.40F or 96.8 0F  
 WBC count  > 12,000 or 
 < 4,000 cells/ mm 3 or  
 >10% immature neutrophils. 
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MODIFIED CT SEVERITY INDEX 
MCTSI was calculated from CECT within 48 hours. 
Modified CT Severity Score is calculated as follows: 
Normal Pancreas  Point  0 
Intrinsic Pancreatic Abnormality 
with Peripancreatic fat stranding 
Point  2 
Peripancreatic fluid collection  Point 4 
Pancreatic Necrosis   
 Absent 
< 30 percent  
≥ 30 percent 
 
Point 0 
Point 2 
Point 2 
Extra Pancreatic Complications  Point 2 
Using above Score total point is calculated. 
    Patients were closely monitored during the entire stay in hospital and 
evidence of organ failure documented. Patients were classified as mild acute 
pancreatitis and severe acute pancreatitis based on the presence of organ 
failure that persists for more than 48 hours. 
 Organ failure is defined by  
i) Shock (Systolic BP <90 mm Hg) 
51 
 
ii) Pulmonary Insufficiency (PO2 <60mm Hg at room air or need 
of mechanical ventilator) 
iii) Renal Failure (serum creatinine>2mg/dl after rehydration or 
hemodialysis) 
Pancreatic necrosis was assessed from CECT. Pancreatic necrosis is 
defined as lack of enhancement of pancreatic parenchyma with contrast. 
Comparison of prediction of severity of acute pancreatitis by BISAP and 
MCTSI score is the primary outcome of interest and comparison of 
prediction of mortality and pancreatic necrosis by both scores is the 
secondary outcome of interest.  
STATISTICAL ANALYSIS 
The data collected were entered in Microsoft Excel. The categorical 
data were expressed as percentage. The continuous data were expressed in                        
Mean ± Standard Deviation. For the comparison of two groups, Unpaired T 
test was used. When more than two groups were compared ANOVA was 
used as the statistical tool. Categorical data and influence of the factors on 
severity were assessed using chi square test. For all analytical purpose, SPSS 
Software version  21.0 was used a value less than 0.05 was considered 
significant. 
  
Of the total of 100 patients studied in the study, most of the patients 
(41%) were in the age group of 31 
50 years and 24% of patients were below 30 
RESULTS AND OBSERVATION
AGE DISTRIBUTION
Table 1. Age Distribution
AGE  NO OF PATIENTS
< 30 years  
31-40 years 
41-50 years 
51-60 years 
> 60 years 
Chart 1. Age D
–
20
6
9
AGE DISTRIBUTION
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 PERCENTAGE
24 24%
41 41%
20 20%
6 6% 
9 9% 
istribution 
 40 years. 15% of patients were above 
years of age. 
24
41
< 30
31
41
51
> 60
 
 
 
 
 
-40
-50
-60
  
97% of patients in the study are males. Other Indian studies also 
revealed similar gender distribution pattern, the 
male prepond
male population of India. 
SEX DISTRIBUTION
Table 2. Sex Distribution
Chart 2. Sex Distribution
erance is due to high incidence of alcohol consumption in a 
 
3%
NO OF PATIENTS
MALE
SEX NO OF PATIENTS
MALE 
FEMALE 
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majority being males. This 
97%
FEMALE
 PERCENTAGE
97 97% 
3 3% 
 
 
54 
 
ETIOLOGY  
 
Table 3. Etiology of Acute Pancreatitis 
ETIOLOGY NO OF PATIENTS PERCENTAGE 
ALCOHOL 46 46% 
GALL STONES 27 27% 
IDIOPATHIC 24 24% 
POST ERCP 2 2% 
HYPERLIPIDEMIA 1 1% 
 
 
Chart 3. Etiology of Acute Pancreatitis 
 
In our study, alcohol was found to be the most common etiology of 
acute pancreatitis contributing 46% of cases followed by gallstones 
contributing 27% of cases. Hyperlipidemia and Post ERCP were also found 
to be rare causes contributing 1 and 2 % respectively. 
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ETIOLOGY
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In our study, all patients presented with abdominal pain which was 
radiated to back in 64% of cases. 
78% of cases.On examination, guarding was present in 88% of cases.
SIGNS AND SYMPTOMS
Table 4. Signs and Symptoms
SYMPTOMS PRESENT
PAIN 
RADIATION 
VOMITING 
GUARDING 
Chart 4. Signs and Symptoms
The p
PAIN RADIATION
100%
64%
0%
36%
SIGNS AND SYMPTOMS
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 ABSENT
100% 0%
64% 36%
78% 22%
88% 12%
 
 
ain was associated with vomiting
VOMITING GUARDING
78%
88%
22%
12%
ABSENT
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 HOSPITAL STAY
Most of the cases of acute pancreatitis (42%) were discharged in less 
than 5 days. 24% of patients stayed in the 
patients, 
stay was found to be directly rel
discharged patients. 
HOSPITAL STAY
Table 5. Hospital Stay
 NO OF PATIENTS
< 5 DAYS 
5-10 DAYS 
> 10 DAYS 
Chart 5. Hospital Stay
the stay prolonged for more than 10 days. The length of hospital 
ated to BISAP score and MCTSI score for 
 
50%
24%
26%
HOSPITAL STAY
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 PERCENTAGE
50 50%
24 24%
26 26%
 
 
 
 
hospital for 5 – 10 days.In 26% of 
< 5 DAYS
5-10 DAYS
> 10 DAYS
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STATISTICS OF AGE, HOSPITAL STAY AND 
AMYLASE LEVEL 
 
Table 6. Statistics of Age, Hospital Stay and Amylase level 
 
Age 
Hospital 
Stay Amylase 
Mean 39.65 9.52 563.02 
Median 38.00 5.50 464.50 
Std. Deviation 12.373 8.736 232.255 
Range 56 37 1000 
Minimum 15 3 309 
Maximum 71 40 1309 
 
Percentiles 
25 32.00 4.00 384.25 
50 38.00 5.50 464.50 
75 46.75 11.00 734.25 
 
The mean age of patients in the study is 39 years. The minimum age is 
15 years and the maximum age is 71. The mean length of hospital stay is 10 
days. Minimum hospital stay was for 3 days and maximum for 40 days. 
Mean amylase level of the patients in the study was 563 IU. The highest 
amylase value was 1309 IU and lowest was 309 IU. 
 
 
 Of the total 100 cases, 29 cases fulfilled the criteria of Severe Acute 
Pancreatitis (SAP) by Atlanta Classification. This was taken as the standard 
to compare BISAP score and MCTSI.
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SEVERITY ( BY ATLANTA CLASSIFICATION)
Table 7. Severity classification based on Atlanta classification
SEVERITY NO OF PATIENTS
SEVERE 
MILD 
Chart 6. Severity classification based on Atlanta classification
29
SEVERE
SEVERITY ( by Atlanta Classification )
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 PERCENTAGE
29 29%
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ORGAN FAILURE IN SEVERE ACUTE PANCREATITIS 
Of the total 29 cases of SAP diagnosed to have organ failure that 
persisted more than 48 Hrs, majority (48%) was found to had Cardiovascular 
System failure which presented as shock and hypotension.35% of patients 
had renal failure and Respiratory failure was found in 35% of patients 
A.RESPIRATORY FAILURE IN SEVERE PANCREATITIS 
PATIENTS 
Table 8. Respiratory failure among severe pancreatitis 
RESPIRATORY FAILURE NO OF PATIENTS(N=29) PERCENTAGE 
PRESENT 10 35% 
ABSENT 19 65% 
 
 
Chart 7. Respiratory failure among severe pancreatitis 
10
19
PRESENT ABSENT
RESPIRATORY FAILURE IN  SEVERE 
PANCREATITIS  PATIENTS
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CARDIAC FAILURE IN SEVERE PANCREATITIS PATIENTS 
 
Table 9.Cardiac failure among severe pancreatitis 
 
CARDIAC FAILURE NO OF PATIENTS(N=29) PERCENTAGE 
PRESENT 14 48% 
ABSENT 15 52% 
 
 
 
 
Chart 8. Cardiac failure among severe pancreatitis 
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RENAL FAILURE IN PATIENTS WITH SEVERE PANCREATITIS
 
 
RENAL FAILURE
Table 10.Renal failure among severe pancreatitis
 NO OF PATIENTS(N=29)
PRESENT 
ABSENT 
Chart 9. Renal failure among severe pancreatitis
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 PERCENTAGE
10 35%
19 65%
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The proportion of subjects with acute pancreatitis stratified with 
BISAP point score is presented in
severity was seen with increasing BISAP score.
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BISAP SCORE
 table.11
Table 11.Stratification of patients based on 
 NO OF PATIENTS
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Chart 10.Stratification of patients based on 
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. A significant trend of disease 
 
BISAP score 
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 The proportion of subjects with acute pancreatitis stratified with 
MCTSI score is presented in
MCTSI
 
 
MODIFIED CT SEVERITY INDEX
 table.12.
Table 12. Stratification of patient based on MCTSI
 SCORE NO OF PATIENTS
ZERO 31
TWO 38
FOUR 15
SIX 11
EIGHT 5 
Chart 11. Stratification of patients based on MCTSI score
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RECEIVER OPERATING CHARACTERISTIC CURVE  
 
Chart 12. Receiver Operating Characteristic curve of severity 
Reciever Operator Characteristic Curves of BISAP and CTSI scores 
in predicting severity were plotted and pairwise comparison was done. The 
AUC for BISAP and CTSI was 0.917 (95% CI 0.864–0.970) and 0.853 
(95% CI 0.777– 0.928), respectively. On the basis of highest sensitivity and 
specificity values generated from the receiver – operating characteristic 
curves, the following cutoff’s were selected for assessing severity: 
BISAP score  3, and a CTSI ≥4. 
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STRATIFICATION BASED ON CUT-OFF OF BOTH SCORES 
 
Table 13. BISAP ≥ 3 vs BISAP < 3 
BISAP SCORE NO OF PATIENTS PERCENTAGE 
BISAP >= 3 24 24% 
BISAP < 3 76 76% 
 
 
Table 14. MCTSI ≥ 4 vs MCTSI <4 
MCTSI NO OF PATIENTS PERCENTAGE 
MCTSI >= 4 31 31% 
MCTSI < 4 69 69% 
Chart 13.A. BISAP ≥ 3 vs BISAP< 3.   B. MCTSI ≥ 4 vs MCTSI <4 
 
Among 100 patients 24% of patients had BISAP ≥ 3 and 76% of 
patients had BISAP < 3. 31% of patients had MCTSI ≥ 4 and 69 had MCTSI 
< 4. 
 
66 
 
SERUM AMYLASE – SEVERITY CORRELATION 
 
Table 15.serum amylase – severity correlation 
SEVERITY MEAN SD 
SEVERE 793.86 163.83 
MILD 468.73 214.91 
     P VALUE 0.001                                                                         UNPAIRED T TEST 
 
 
Chart 14.serum amylase – severity correlation 
 
The mean S.Amylase level of patients with Severe Acute Pancreatitis 
(SAP) was found to be 793.86 ± 163.83 U/L and those with mild acute 
pancreatitis is 468.73 ± 214.91 U\L. P Value was found to be 0.001 which 
was statistically significant. Both levels are above three times the normal 
S.Amylase level. 
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ZERO
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P-VALUE :
S.Amylase
Table.16 and plotted in Chart.15. The 
ANOVA test and was found to be 0.001 which is statistically 
significant.With the 
the S.Amylase level.
Table 16.Amylase  correlation with BISAP score
 MEAN
 403.6
ONE 483.6
TWO 631.37
 785.2
 956.11
 0.001                                                                            
Chart 15.Amylase correlation with BISAP score
 level stratified by the BISAP point score is presented in 
increase in BISAP 
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  SD 
 67.26 
 121.66 
 240.56 
 165.15 
 188.26 
ANOVA
 
P Value was calculated using 
score, there is an increasing t
631.37
785.2
956.11
TWO THREE FOUR
 
 
 
rend in 
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AMYLASE LEVEL CORRELATION WITH MCTSI 
 
Table 17.Amylase correlation with MCTSI 
MCTSI SCORE MEAN SD 
ZERO 434.34 102.89 
TWO 475.68 142.55 
FOUR 682.13 195.36 
SIX 851.09 233.5 
EIGHT 1025.8 222.62 
P VALUE 0.001                                                                                 ANOVA 
 
 
Chart 16. amylase correlation with MCTSI 
 
S.Amylase level stratified by the MCTSI score is presented in 
Table.17 and plotted in Chart16. The P Value was calculated using ANOVA 
test and was found to be 0.001 which is statistically significant.With the 
increase in MCTSI, there is an increasing trend in the S.Amylase level. 
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PREDICTION OF SEVERITY OF DISEASE WITH BISAP SCORE 
 
Table 18.Prediction of severity with BISAP score 
BISAP SCORE SEVERE MILD 
BISAP >= 3 19 5 
BISAP < 3 10 66 
TOTAL 29 71 
 
 
 
Chart 17.Prediction of severity with BISAP score 
 
  Severe and mild pancreatitis cases with BISAP ≥ 3 and BISAP < 3 are 
tabulated in the table18.Among the total 29 cases of severe acute 
pancreatitis, 19 cases were found to have BISAP score ≥ 3 and 10 cases had 
a score <  3.  
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PREDICTION OF SEVERITY WITH MCTSI 
 
Table 19.Prediction of severity with MCTSI 
MCTSI SEVERE MILD 
MCTSI >= 4 20 11 
MCTSI < 4 9 60 
TOTAL 29 71 
 
 
 
Chart 18.Prediction of severity with MCTSI 
 
Severe and mild pancreatitis case with MCTSI ≥ 4 and MCTSI < 4 are 
tabulated in the table19.Of the 29 cases of SAP, 20 cases had MCTSI ≥ 4 
and 9 cases had score < 4.  
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SENSITIVITY, SPECIFICITY, PPV, NPV COMPARISON OF BISAP 
AND MCTSI IN PREDICTING SEVERITY 
 
Table 20. Sensitivity, Specificity, PPV, NPV comparison of BISAP and MCTSI in 
predicting severity 
SCORING SYSTEM BISAP MCTSI 
SENSITIVITY 65.52% 68.97% 
SPECIFICITY 92.96% 84.51% 
POSITIVE PREDICTIVE VALUE 79.17%. 64.52% 
NEGATIVE PREDICITIVE VALUE 86.84% 86.96% 
. 
The Specificity, Sensitivity. Positive Predictive Value and Negative 
Predictive Value of both BISAP and MCTSI in predicting the severity of 
acute pancreatitis was calculated. The Specificity and Positive Predictive 
Value of BISAP score were higher than the MCTSI in predicting the 
severity. Comparable Negative Predictive Values were seen for both BISAP 
score and MCTSI. The ROC analysis for severity showed BISAP score had 
AUC of 0.917 which was more than MCTSI score which had AUC of 0.853.  
Hence the accuracy of BISAP score in predicting the severity of acute 
pancreatitis is more when compared with MCTSI. 
 
 
  
 
 
 
 
Of the total 100 patients, CT scan done within 48Hrs revealed 
pancreatic necrosis in 19 cases.
PANCREATIC NECROSIS
Table 21. Pancreatic necrosis in patients with SAP
NECROSIS NO OF PATIENTS
PRESENT 
ABSENT 
Chart 19.Pancreatic necrosis in patients with SAP
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 PERCENTAGE
19 19% 
81 81% 
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BISAP SCORE STRATIFICATION IN PANCREATIC NECROSIS 
 
Table 22. BISAP score stratification for Necrosis 
BISAP SCORE NECROSIS IN 
SEVERE CASES 
NECROSIS IN MILD 
CASES 
BISAP >=3 6 3 
BISAP < 3 1 9 
TOTAL 7 12 
 
 
 
Chart 20.BISAP score stratification for Necrosis 
 
By performing CT scan in the first 48 Hrs, necrosis was identified in 7 
out of 29 severe cases and 12 out of 71 mild cases of acute pancreatitis. Of 
the 7 severe cases, 6 cases had BISAP ≥3. Of the 12 mild cases, 3 showed 
BISAP ≥ 3. 
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MCTSI STRATIFICATION IN PANCREATIC NECROSIS 
 
Table 23.MCTSI score stratification for Necrosis 
 
MCTSI NECROSIS IN 
SEVERE CASES 
NECROSIS IN MILD 
CASES 
MCTSI >= 4 7 9 
MCTSI < 4 0 3 
TOTAL 7 12 
 
 
 
 
 
 
Chart 21.BISAP score stratification for Necrosis 
 
Out of the 19 cases of pancreatic necrosis, all 7 severe cases had 
MCTSI ≥ 4 and 9 out of 12 mild cases of pancreatitis had MCTSI ≥ 4.  
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Chart 
The Sensitivity, Specificity, Positive Predictive Value and Negative 
Predictive Value of both BISAP score and MCTSI in predicting pancreatic 
necrosis 
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85.71%
75.00%
100.00%
75.00%
SENSITIVITY SPECIFICITY
PANCREATIC NECROSIS
BISAP
75 
 BISAP MCTSI
85.71% 100.0%
75.00% 75.00%
66.67% 83.75%
 90.00% 100.00%
3.96 
66.67%
90.00%83.75%
100.00%
POSITIVE PREDICTIVE 
VALUE
NEGATIVE PREDICITIVE 
VALUE
MCTSI
 
 
 
 
 
 
 
23 
 
 
76 
 
necrosis than MCTSI < 4. Hence MCTSI is more accurate in predicting 
necrosis compared to BISAP score.  
MORTALITY 
 
Table 25.Mortality Statistics 
OUTCOME NO OF PATIENTS PERCENTAGE 
DIED 8 8% 
DISCHARGED 92 92% 
 
 
 
Chart 23.Mortality Statistics 
Of the total 100 patients in the study, 8 patients died in the course of 
treatment. 92 patients were discharged. All the dead patients were diagnosed 
to have severe acute pancreatitis.All of them were having BISAP score  ≥ 3 
and CTSI  ≥ 4. 
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MORTALITY vs BISAP SCORE 
Table 26.Mortality vs BISAP score 
BISAP SCORE DEAD DISCHARGED 
BISAP >= 3 8 16 
BISAP < 3 0 76 
P VALUE :0.001                                                                               ODDS RATIO: 38 
CHI SQUARE TEST 
 
 
Chart 24.Mortality vs BISAP score 
 
Among the 8 expired patients in the study all of them had a BISAP 
score ≥ 3.  16 out of 92 discharged patients also had a BISAP score ≥ 3.P 
value was calculated to be 0.001 which was statistically significant. The 
odds ratio was calculated to be 38. Based on BISAP score patient who has 
score ≥ 3  has Thirty Eight fold higher chance of ending up in mortality than 
patients with a score < 3 , which is statistically significant. 
0
10
20
30
40
50
60
70
80
DEAD DISCHARGED
N
o 
of
 P
at
ie
nt
s
Outcome
BISAP >= 3
BISAP < 3
 MCTSI >= 4
MCTSI < 4
P VALUE
Among the 8 expired patients in the 
score ≥ 4. 23 out of 92 discharged patients also had a MCTSI score ≥ 4. P 
value was calculated to be 0.001 which was statistically significant. 
ratio was calculated
≥ 4 has Twenty Four fold higher 
statistically significant. Comparing BISAP and MCTSI, BISAP having high 
odds ratio predicts mortality more accurately.
MORTALITY vs MCTSI SCORE
Table 27.Mortality vs MCTSI score
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Chart 25.Mortality vs MCTSI score
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DISCUSSION 
 Acute pancreatitis is a condition with high incidence and is associated 
with significant mortality rates. Therefore determining the severity in 
patients with acute pancreatitis is important in triaging patients to either 
wards or intensive care units to provide the best outcome. The present study 
compares BISAP score which is a clinical scoring system with MCTSI, 
which is a radiological score in predicting severity, mortality, and necrosis in 
100 patients with acute pancreatitis. 
DEMOGRAPHY 
The median age for acute pancreatitis in the study done by Cornfield 
et al on 418 patients was 61 years. Nordestgaard et al did a study on 51 
patients with acute pancreatitis with a mean age of 44 years. In the present 
study mean age of patients presenting with acute pancreatitis is 39 years. 
 In this study males were 97% and females were 3%.This is in contrast 
to most western studies where both sexes is equally affected. An Indian 
study conducted by Vaidya et al revealed similar age and sex distribution. 
This male preponderance is due to the significant incidence of alcohol 
consumption in the male population of rural India. 
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 Alcohol and gallstone are the most common etiological factors of 
acute pancreatitis. In the original BISAP study by Wu et al, gallstone 
contributed 23.8% cases and alcohol was responsible in 21.1% cases. In the 
present study alcohol is the most common etiological agent contributing 
46% followed by gallstones contributing 27%. Other Indian studies also 
showed the similar distribution in etiological agents. This may be attributed 
to the difference in dietary, social, genetic and cultural factors between 
Indian population and Western population 
COMPARISON OF SCORING SYSTEMS 
 In our study 29 out of 100 patients (29%) developed severe acute 
pancreatitis. The AUC for prediction of severity by BISAP and MCTSI 
score are 0.917 ( 95% CI 0.864 – 0.970) and 0.853 (95% CI 0.777 – 0.928) 
respectively. The in-hospital mortality rate is 8% 
 In 2010, Papachristou et al conducted a study of 185 patients which 
showed AUC for predicting severity in acute pancreatitis for BISAP and 
MCTSI as 0.81 and 0.84 respectively. A study done by Gompertz et al in 
2012 noted BISAP score ≥ 3 had a sensitivity, specificity, positive and 
negative predictive values of 71.4, 99.1, 83.3 and 98.3 % respectively in 
predicting severity. The present study also had high specificity and negative 
81 
 
predictive value compared with that of MCTSI ≥4 in predicting severity in 
acute pancreatitis. 
 Singh and colleagues from Harvard Medical School studied 397 cases 
of acute pancreatitis.They observed that cases with BISAP score ≥3 were 4 
times more likely to develop pancreatic necrosis than those with a score < 
3.Case with MCTSI ≥ 4 were 18 times more likely to develop pancreatic 
necrosis compared with cases with a score < 4. In our study also cases with 
BISAP score ≥ 3 had a 4 times more chance to develop pancreatic necrosis 
than those with a score < 3. Also, patients with MCTSI ≥ 4 has 23 times 
more chance to develop pancreatic necrosis than those with score < 4.  A 
study by Yadhav et al concluded that MCTSI predicts pancreatic necrosis 
more accurately than BISAP score. Present study also derived at the same 
conclusion 
 Wu et al showed in their study that 18% of patients with BISAP ≥ 3 
died and only  1% of those with a score < 3 died in the study.In the present 
study 50% of patients with BISAP score ≥ 3 died and no patients with 
BISAP < 3 expired. In the present study patients with BISAP ≥3 had thirty 
eight times more chance of ending up in death compared to those with 
BISAP < 3. These results are comparable to other similar studies. 
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CONCLUSION 
Individual response to pancreatic injury is highly variable and 
unpredictable in most of the times. To classify patients with acute 
pancreatitis into mild and severe groups, BISAP is a reliable prognostic tool. 
The components of  BISAP are clinically relevant and easy to obtain. The 
sensitivity of BISAP score ≥ 3 in predicting severe acute pancreatitis was 
found to be 65.52%. The negative predictive value of BISAP score in 
predicting severity is much higher at 86.84%.If  only BISAP score of 0 or 1 
were considered, only 3 out of 60  patients (5%) had severe pancreatitis. 
Hence it is safe to consider that patients with BISAP score 0 or 1 will be 
having mild pancreatitis and CT scan can be avoided in such patients. 
However, 7 out of 16 patients(43%) with BISAP score 2 were found to have 
acute pancreatitis. Therefore CT scan must be done in all patients with 
BISAP score 2. AUC concludes that BISAP score is an ideal tool in 
predicting severity in Acute Pancreatitis. 
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DATA COLLECTION PROFORMA 
Name :      Age: 
Sex:       Case Number: 
IP No:     Length of Hospital Stay: 
Serum Amylase:    Etiology: 
SIGNS AND SYMPTOMS 
Abdominal Pain Present Absent 
Guarding Present Absent 
Rigidity Present Absent 
Vomiting Present Absent 
 
Pulse Rate:     Respiratory Rate: 
Temperature:    WBC count: 
SIRS:    Present / Absent 
Pancreatic Necrosis: Present / Absent 
 
Blood Urea Nitrogen: 
Impaired Mental Status : Yes / No 
SIRS: Yes / No 
Age more than 60: Yes / No 
Pleural Effusion: Yes / No 
BISAP Score:     MCTSI : 
 
ORGAN FAILURE: 
Respiratory System Present Absent 
Cardiovascular System Present Absent 
Renal System Present Absent 
 
SEVERITY: Mild / Severe 
OUTCOME: Dead / Discharged  
 
 
CONSENT FORM 
PART 1 0F 2 
Dear Volunteers,  
We welcome you and thank you for your interest in participating in 
this research project. Before you participate in this study, it is important for 
you to understand why this research is being carried out.this form will 
explain you all the relevant details of this research .it will explain the 
nature,thepurpose,thebenefits,the risks, the discomforts,the precautions and 
the information about how this project will be carried out. It is important that 
you read and understand the contentsof the form carefully. 
TITLE OF THE PROJECT:  “A COMPARATIVE EVALUATION OF 
CLINICAL AND RADIOLOGICAL SCORING SYSTEMS IN THE 
EARLY PREDICTION OF SEVERITY IN ACUTE PANCREATITIS” 
Name of the investigator: 
What is the purpose of this project/study? 
To compare BISAP and MCTSI in predicting the severity in acute 
pancreatitis 
How will the study be carried out? 
All patients of acute pancreatitis who the fit inclusion criteria will be 
included in study. For this research only data will be collected and no 
intervention will be done. 
 Following datas will be collected: 
Demographics (age,gender) 
 Etiology 
 Blood investigations 
a) Complete blood count 
b) Blood urea and creatinine 
 Imaging studies(ultrasonography/CECT),chest X-ray 
 Clinical and severity scores and radiological scores 
Following is the Inclusion criteria: All patients admitted with the diagnosis 
of Acute Pancreatitis based on the presence of at least two of the following 
three criteria: 
1. Characteristic epigastric abdominal pain , with or without radiation to 
the back. 
2. Serum amylase or lipase levels elevated to at least three times the 
upper limit of normal. 
3. Characteristic finding of Acute Pancreatitis on abdominal CT scan. 
What is the expected duration of the subject participation? 
No additional stay in hospital is required than the usual course. 
What are the benefits to be expected from the researchto the participant 
or to others and the post-trial responsibilities of the investigator? 
No direct benefit to the participants. At the end of study we will be able to 
find some factors which predict the severity in early phase of acute 
pancreatitis. 
What are the risk factors expected from the study  to the participants? 
No risk as this is only an analytical study. 
Whether my participation in the study will be kept confidential ? 
Yes,confidentiality of records will be maintained. 
Is there provision of free treatment for research related injury? 
No intervention will be done for research purpose. So no research related 
injury is expected. 
Can I withdraw from study when I want? 
Yes. You can withdraw at any time without giving reason and this decicsion 
will not affect your regular medical care. 
 PARTICIPANT  CONSENT FORM  
PART 2 OF 2 
Participants name:                                                             Address: 
 
Title of the project: 
“A COMPARATIVE EVALUATION OF CLINICAL AND 
RADIOLOGICAL SCORING SYSTEMS IN THE EARLY 
PREDICTION OF SEVERITY IN ACUTE PANCREATITIS” 
The details of the study have been provided to me in writing and 
explained to me in my own language. I confirm that I have understood the 
above study and had the opportunity to ask questions. I understand that my 
participation in the study is voluntary and that I am free to withdraw at any 
time, without giving any reason, without the medical care that will normally 
be provided by the hospital being affected. I agree not to restrict the use of 
any data or results that arise from this study provided such a use is only for 
scientific purpose. I have been given information sheet giving details of the 
study. I fully consent to participate in the above study. 
I also consent /do not consent to use my stored biological samples for future 
scientific purposes –if applicable 
 
Signature of the participant:      Date: 
 
Signature of the witness:       Date 
 
Signature of the investigator:      Date: 
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Gender 
  Male   1 
  Female  2  
Etiology 
  Alcohol   1 
  Gall Stones   2 
  Idiopathic   3 
  Post ERCP   4 
          Hyperlipidemia  5 
Signs and Symptoms       Present      Absent 
  Abdominal Pain  1   2 
  Radiation to Back  1   2 
  Guarding   1   2 
  Vomiting   1   2 
Atlanta Criteria for classification of Pancreatitis 
  Severe pancreatitis  1 
  Mild Pancreatitis  0 
Organ failure         Present       Absent 
  Respiratory   1   0 
  CVS    1   0 
  Renal Failure  1    0 
Necrosis           Present        Absent 
      1   0 
Outcome Death    1 
  Discharged   0 
SI.No Name Age Sex IP No
Hospital 
Stay 
Etiology Pain Radiation Vomiting Guarding Amylase BISAP
Atlanta 
Class
MCTSI resp fail cvs fail renal fail Necrosis Outcome
1 vellingiri 50 1 6531 5 1 1 1 1 1 389 0 0 0 0 0 0 0 0
2 Veerappan 65 1 6821 6 1 1 1 2 1 451 0 0 0 0 0 0 0 0
3 Murugavel 26 1 6966 4 2 1 1 1 2 643 2 1 2 1 0 0 0 0
4 Sateesh Kumar 36 1 7031 17 1 1 2 1 1 698 3 0 4 0 0 0 0 0
5 Selvam 40 1 7186 10 3 1 1 2 1 421 0 0 2 0 0 0 0 0
6 Anand 47 1 7252 5 1 1 1 1 1 397 0 0 2 0 0 0 0 0
7 Sakthivel 25 1 7459 3 2 1 1 1 1 512 1 1 2 0 1 0 0 0
8 Goutham 15 1 7682 4 1 1 2 2 1 743 2 0 2 0 0 0 0 0
9 Francis 48 1 8216 3 3 1 1 1 1 432 1 0 0 0 0 0 0 0
10 Varatharajan 32 1 8337 4 1 1 2 1 1 388 0 0 0 0 0 0 0 0
11 Velusamy 40 1 8416 12 2 1 2 1 2 402 0 0 2 0 0 0 0 0
12 Anand 26 1 8617 7 1 1 1 2 1 514 2 1 2 0 0 1 0 0
13 Chandran 49 1 8911 20 2 1 2 1 1 597 2 0 4 0 0 0 1 0
14 Kajamoideen 35 1 9436 4 1 1 2 1 1 409 0 0 0 0 0 0 0 0
15 Nagarajan 37 1 10396 5 1 1 1 1 1 383 0 0 2 0 0 0 0 0
16 kaliyappan 65 1 11672 24 2 1 1 1 1 1212 3 1 6 0 0 1 0 0
17 SureshKumar 39 1 11689 4 1 1 1 1 1 533 0 0 0 0 0 0 0 0
18 Ashok Kumar 24 1 23168 13 3 1 2 2 1 612 0 0 2 0 0 0 0 0
19 Ganeshan 59 1 28823 3 2 1 1 1 1 678 1 1 2 0 1 0 0 0
20 Varatharaj 54 1 22220 24 3 1 1 1 1 912 3 1 4 0 0 1 0 0
21 Chinnaraj 40 1 31615 5 3 1 2 1 1 803 2 0 0 0 0 0 0 0
22 Nagaraj 38 1 36311 3 2 1 1 1 1 1209 4 1 8 1 0 0 1 1
23 Arun Kumar 29 1 36558 11 1 1 2 1 1 504 0 0 2 0 0 0 0 0
24 Sikkandar Bhasha 26 1 40046 6 2 1 1 2 1 612 0 0 0 0 0 0 0 0
25 Sivakumar 35 1 47733 5 2 1 2 1 1 499 1 0 2 0 0 0 0 0
26 Mahendran 33 1 47978 4 1 1 1 1 1 1309 4 1 8 0 1 0 1 1
27 raghupathy 40 1 44409 36 1 1 1 1 1 917 3 1 8 0 1 0 1 0
28 Kaja 45 1 92625 5 1 1 2 1 1 509 1 0 2 0 0 0 0 0
SIGNS/SYMPTOMS ORGAN FAILURE
29 kannan 40 1 64057 6 3 1 1 1 2 399 0 0 0 0 0 0 0 0
30 Babu 28 1 64669 10 2 1 2 2 1 457 0 0 2 0 0 0 0 0
31 Mani 44 1 64793 8 1 1 1 1 1 876 4 1 6 1 0 0 0 1
32 Suresh Kumar 34 1 71171 4 1 1 2 1 1 596 1 0 0 0 0 0 0 0
33 Jaganathan 46 1 71176 7 3 1 1 1 1 432 0 0 2 0 0 0 0 0
34 Arun Kumar 30 1 71229 6 2 1 1 1 1 769 3 1 6 0 1 0 0 1
35 Murugavel 35 1 73923 3 1 1 2 1 1 601 1 0 0 0 0 0 0 0
36 Sareeg Dher 23 1 74504 8 3 1 1 2 1 413 0 0 2 0 0 0 0 0
37 Ammasai 68 2 4917 3 2 1 1 1 1 781 4 1 8 1 1 1 1 1
38 Suresh 47 1 74865 6 1 1 2 1 1 612 1 0 2 0 0 0 0 0
39 Krishnakumar 35 1 76395 5 1 1 2 1 1 347 0 0 0 0 0 0 0 0
40 Karuppanan 71 1 39641 8 1 1 1 1 2 708 3 1 4 0 1 0 0 0
41 Kiran 25 1 41788 12 2 1 1 1 1 339 1 0 2 0 0 0 0 0
42 Jayachandran 29 1 41828 4 1 1 2 1 1 400 0 0 0 0 0 0 0 0
43 Ganeshan 35 1 9152 16 3 1 1 1 1 748 3 1 4 1 0 0 0 0
44 Gukan 29 1 43414 38 2 1 2 1 1 812 4 0 6 0 0 0 1 0
45 Dinesh 25 1 45283 4 2 1 2 2 1 413 0 0 2 0 0 0 0 0
46 manikandan 38 1 10092 10 3 1 1 1 1 913 4 1 8 1 1 1 1 1
47 Surendran 40 1 51192 3 2 1 1 1 1 316 0 0 0 0 0 0 0 0
48 Surya 28 1 85320 5 1 1 1 1 1 801 4 1 6 0 0 1 0 1
49 Balan 32 1 86442 3 1 1 2 1 1 421 0 0 0 0 0 0 0 0
50 Palanisamy 64 1 26207 25 2 1 1 1 1 697 3 1 4 1 0 1 0 0
51 Manoharan 37 1 86996 9 3 1 1 1 1 410 0 0 2 0 0 0 0 0
52 Selvaraj 35 1 90423 6 3 1 2 2 1 543 2 1 2 0 1 0 0 0
53 Siddharth 23 1 79408 4 1 1 2 1 2 366 0 0 0 0 0 0 0 0
54 Faharudeen 50 1 79488 5 3 1 1 1 1 345 0 0 2 0 0 0 0 0
55 Suresh 37 1 80524 12 1 1 1 1 1 547 1 0 4 0 0 0 1 0
56 Raju 52 1 51438 28 1 1 1 1 1 794 3 1 6 0 1 0 1 0
57 Mani 35 1 81005 32 2 1 1 1 1 659 3 0 6 0 0 0 1 0
58 Arokyadas 37 1 2503 5 3 1 2 2 1 361 0 0 0 0 0 0 0 0
59 Velusamy 38 1 2625 4 3 1 1 1 2 494 1 0 2 0 0 0 0 0
60 Suresh 37 1 83681 20 1 1 1 1 1 669 3 1 4 0 1 0 0 0
61 Tirupathi 35 1 9382 22 1 1 1 1 1 338 2 0 4 0 0 0 1 0
62 Krishnakumar 35 1 11124 3 2 1 2 2 1 376 1 0 2 0 0 0 0 0
63 Krishnasami 54 1 17376 3 1 1 2 1 1 443 0 0 0 0 0 0 0 0
64 Velusami 37 1 28319 11 3 1 1 1 1 865 3 1 4 1 0 0 0 0
65 Nagaraj 40 1 18174 18 2 1 1 1 1 470 3 0 4 0 0 0 0 0
66 Najeeb 38 1 29735 7 4 1 2 1 2 377 0 0 2 0 0 0 0 0
67 Chandrashekar 67 1 36862 4 1 1 2 2 1 412 1 0 0 0 0 0 0 0
68 Veerasamy 40 1 20981 4 3 1 1 1 1 877 4 1 6 0 1 0 0 1
69 Sentil Kumar 42 1 36154 8 1 1 1 1 1 312 0 0 2 0 0 0 1 0
70 Raja 22 1 38140 4 3 1 1 2 1 376 0 0 0 0 0 0 0 0
71 Nataraj 45 1 91542 27 1 1 1 1 1 1027 4 1 4 0 0 1 0 0
72 Nagaraj 40 1 38930 4 1 1 1 1 1 330 1 0 0 0 0 0 0 0
73 chandran 41 1 39866 5 1 1 2 2 1 406 0 0 0 0 0 0 0 0
74 Padmanabhan 46 1 57166 3 3 1 2 1 2 514 1 0 0 0 0 0 0 0
75 Jaya 49 2 10636 6 5 1 1 1 1 876 2 1 2 1 0 0 0 0
76 Ajith Kumar 19 1 35315 34 2 1 1 1 1 1269 2 0 6 0 0 0 1 0
77 Rajeev 45 1 82664 4 1 1 1 2 1 430 0 0 0 0 0 0 0 0
78 Bunnan 57 1 70230 4 1 1 2 1 1 315 1 0 2 0 0 0 0 0
79 Rajan 35 1 75533 9 1 1 1 1 2 356 2 0 4 0 0 0 1 0
80 Stephan 37 1 32318 40 3 1 2 1 1 875 3 0 6 0 0 0 1 0
81 Arumugam 49 1 31730 4 2 1 1 1 1 344 0 0 0 0 0 0 0 0
82 Jude Charles 30 1 77562 4 4 1 1 2 1 309 0 0 2 0 0 0 0 0
83 Sakthivel 26 1 82679 9 3 1 1 2 1 766 2 1 2 0 0 1 0 0
84 Dharman 54 1 86629 4 2 1 2 1 2 379 0 0 0 0 0 0 0 0
85 Murugeshan 65 1 82407 10 1 1 1 1 1 743 1 1 2 0 1 0 0 0
86 Arun Kumar 22 1 82858 6 2 1 1 1 1 522 2 0 2 0 0 0 1 0
87 Musthafa 50 1 84242 7 1 1 2 1 1 320 0 0 2 0 0 0 0 0
88 Shekar 36 1 80643 12 3 1 1 2 1 365 1 0 2 0 0 0 0 0
89 rangasamy 46 1 86301 5 1 1 1 1 1 370 0 0 0 0 0 0 0 0
90 Chithra 38 2 75429 30 3 1 2 1 1 418 2 1 6 1 0 0 1 0
91 Gopinath 37 1 73904 5 1 1 1 1 2 441 2 0 0 0 0 0 0 0
92 Mohan 24 1 87908 5 2 1 1 2 1 367 0 0 2 0 0 0 1 0
93 Parthibhan 23 1 87872 4 1 1 1 1 1 398 0 0 0 0 0 0 0 0
94 Mani 40 1 98564 5 1 1 2 1 1 459 2 1 2 0 0 1 0 0
95 Chinnan 64 1 79761 5 2 1 1 1 2 345 1 0 0 0 0 0 0 0
96 Santhosh 20 1 34501 13 1 1 1 2 1 367 0 0 2 0 0 0 0 0
97 Subbayan 70 1 87961 3 2 1 1 1 1 453 1 0 0 0 0 0 0 0
98 Jagan 34 1 86432 16 1 1 2 1 1 786 3 1 4 0 1 0 0 0
99 ramu 41 1 68710 10 3 1 1 2 1 814 2 0 4 0 0 0 1 0
100 venkadachalam 47 1 12111 4 1 1 1 1 1 365 0 0 2 0 0 0 0 0
